Enveric Biosciences, Inc. Common Stock ENVB
$1.48
+4.23%
at last close
Analyst Consensus
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-03-06 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $10 |
| 2024-01-30 | HC Wainwright & Co.Vernon Bernardino |
Initiates coverage on | Buy | $150 |
| 2022-06-01 | Alliance Global PartnersJames Molloy |
Initiates coverage on | Buy | $938 |
| 2022-03-08 | Aegis CapitalNathan Weinstein |
Downgrades | Buy → Hold | $5250 → $150 |
| 2021-07-08 | Aegis CapitalNathan Weinstein |
Initiates coverage on | Buy | $5250 |
| 2021-06-28 | Maxim GroupJason McCarthy |
Initiates coverage on | Buy | $4500 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $1.48
- Market Cap
- $6.36 million
- 52-Week Range
- $1.17 – $17.64
- Average Volume
- 110K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.